Egyptian Drug Authority Strengthens African Cooperation to Localize Vaccine Manufacturing
The Egyptian Drug Authority participated in the fifth edition of the Africa Health ExCon 2026, which serves as a significant platform for enhancing health cooperation among the continent's nations. This event aims to discuss ways to develop the medical sector and provide innovative solutions to the health challenges facing African populations.
The conference witnessed the participation of Dr. Ali Al-Ghamrawy, Chairman of the Egyptian Drug Authority, in the signing ceremonies for a series of strategic partnerships. These agreements focus primarily on localizing vaccine manufacturing within the African continent, in addition to exchanging expertise and transferring advanced medical technology.
These steps come within the framework of Egypt's efforts to enhance regional health security. Through these partnerships, the Authority seeks to reduce reliance on importing vaccines from abroad and ensure the sustainable and safe provision of needs for citizens in Egypt and African countries.
These initiatives underscore Egypt's leading role in supporting the healthcare system in Africa. It is expected that these agreements will contribute to creating an attractive investment environment in the pharmaceutical industry, thereby enhancing the continent's ability to face future health crises with high efficiency.